Table 2.
Characteristics of participants to the TRELONG study at baseline (2003) by vital status on April 2nd, 2014
| Status on April 2nd. 2014 | Alive | Dead | P-value |
|---|---|---|---|
|
|
|||
| Mean ± SD or % | Mean ± SD or % | ||
| Number (%) | 214 (32.04%) | 454 (67.96%) | |
| Males. n (%) | 84 (39.25%) | 227 (50.00%) | 0.012 |
| Age. median (range) (years) | 76.90 (73.60-81.45) | 88.20 (80.93-92.88) | < 0.0001 |
| BMI (kg/m2) | 25.65 ± 4.02 | 24.31 ± 4.11 | 0.0001 |
| BMI < 18.5 (underweight) | 1.4% | 7.5% | 0.003 |
| 18.5 ≤ BMI < 25 (normal weight) | 42.52% | 43.61% | 0.856 |
| 25 ≤ BMI < 30 (overweight) | 41.12% | 29.74% | 0.005 |
| BMI > 30 (obese) | 12.62% | 8.15% | 0.091 |
| Smoking status smoking (1) | 41.12 | 41.41% | 1.0 |
| Never smoking (0) | |||
| SPPB | 7.995 ± 3.57 | 4.115 ± 3.57 | < 0.0001 |
| CCI | 4.439 ± 1.43 | 6.392 ± 1.96 | < 0.001 |
| MMSE ≤ 24. n (%) | 31 (14.49%) | 183 (46.26%) | < 0.0001 |
| APOE ε4/4 and 4/3. n (%) | 27 (15.00%) | 66 (16.92%) | 0.649 |
| IL-6 median (range) (pg/mL) | 0.59 (0.33-1.30) | 1.12 (0.54-2.61) | < 0.001 |
BMI: body mass index; SPPB: short physical performance battery score; CCI: Charlson co-morbidity index; APOE: apolipoprotein E; IL-6: interleukin-6.